Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03870399
Recruitment Status : Recruiting
First Posted : March 12, 2019
Last Update Posted : May 7, 2019
Sponsor:
Information provided by (Responsible Party):
Rachel Riechelmann, AC Camargo Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 13, 2022
Estimated Study Completion Date : March 13, 2025
Publications: